These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32861385)

  • 81. Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.
    Wang SL; Wang CL; Wang PL; Xu H; Du JP; Zhang DW; Gao ZY; Zhang L; Fu CG; Chen KJ; Shi DZ
    Exp Biol Med (Maywood); 2016 Mar; 241(5):478-84. PubMed ID: 26585407
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Feasibility, Safety, and Effectiveness of a Mobile Application in Cardiac Rehabilitation.
    Nabutovsky I; Ashri S; Nachshon A; Tesler R; Shapiro Y; Wright E; Vadasz B; Offer A; Grosman-Rimon L; Klempfner R
    Isr Med Assoc J; 2020 Jun; 22(6):357-363. PubMed ID: 32558441
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Sex-Specific Differences in Percutaneous Coronary Intervention Outcomes After a Cardiac Event: A Cohort Study Examining the Role of Depression, Worry and Autonomic Function.
    O'Neil A; Scovelle AJ; Thomas E; Russell JD; Taylor CB; Hare DL; Toukhsati S; Oldroyd J; Rangani WPT; Dheerasinghe DSAF; Oldenburg B
    Heart Lung Circ; 2020 Oct; 29(10):1449-1458. PubMed ID: 32414636
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence.
    Borovac JA; Leth-Olsen M; Kumric M; D'Amario D; Schwarz K; Glavas D; Bozic J
    Eur J Clin Pharmacol; 2022 Jan; 78(1):111-126. PubMed ID: 34423376
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical outcomes after percutaneous coronary intervention in non-dialysis patients with acute coronary syndrome and advanced renal dysfunction.
    Uemura Y; Ishikawa S; Takemoto K; Negishi Y; Tanaka A; Takagi K; Yoshioka N; Umemoto N; Inoue Y; Morishima I; Shibata N; Asano H; Ishii H; Watarai M; Murohara T;
    Clin Exp Nephrol; 2020 Apr; 24(4):339-348. PubMed ID: 31903510
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Evaluation of a Hybrid Cardiovascular Rehabilitation Program in Acute Coronary Syndrome Low-Risk Patients Organised in Both Cardiac Rehabilitation and Sport Centres: A Model Feasibility Study.
    Meslet JB; Dugué B; Brisset U; Pianeta A; Kubas S
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35954810
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Efficacy of cilostazol in patients with acute coronary syndrome after percutaneous coronary intervention.
    Hu T; Ma H; Li H; Ren J
    Am J Ther; 2013; 20(2):151-3. PubMed ID: 22975664
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prevalence, correlation and clinical outcome of intra-procedural stent thrombosis in patients undergoing primary percutaneous coronary intervention for acute coronary syndrome.
    Xu Y; Qu X; Fang W; Chen H
    J Interv Cardiol; 2013 Jun; 26(3):215-20. PubMed ID: 23551235
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with non-ST segment elevation acute coronary syndrome.
    Lee T; Murai T; Isobe M; Kakuta T
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):905-914. PubMed ID: 28303685
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Impact of depression and/or anxiety on patients with percutaneous coronary interventions after acute coronary syndrome: a protocol for a real-world prospective cohort study.
    Xiao Y; Li W; Zhou J; Zheng J; Cai X; Guo M; Hao X; Zhang Z; Liu Y; Yuan Z
    BMJ Open; 2019 Sep; 9(9):e027964. PubMed ID: 31492778
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Changes in serum serotonin levels in patients with acute coronary syndrome and stable angina undergoing percutaneous coronary intervention.
    Han D; Choi JH; Kim S; Park SM; Shin DG; Kang MK; Choi S; Lee N; Cho JR
    J Int Med Res; 2020 Dec; 48(12):300060520970104. PubMed ID: 33284714
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Impact of persistent subclinical hypothyroidism on clinical outcomes in non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
    Han C; Xu K; Wang L; Zhang Y; Zhang R; Wei A; Dong L; Hu Y; Xu J; Li W; Li T; Liu C; Qi W; Jin D; Zhang J; Cong H
    Clin Endocrinol (Oxf); 2022 Jan; 96(1):70-81. PubMed ID: 34636447
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Evaluation of Bivalirudin-Associated Major Adverse Cardiac and Hemorrhagic Events in Acute Coronary Syndrome Patients on Chronic Dialysis Following Percutaneous Coronary Intervention.
    Fu D; Liu M; Gao T; Li C; Liao J; Shao M; Xiao X; Yang P; Li X; Jiang H
    J Invasive Cardiol; 2021 Nov; 33(11):E877-E883. PubMed ID: 34653957
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Health-related quality of life and exercise-based cardiac rehabilitation in contemporary acute coronary syndrome patients: a systematic review and meta-analysis.
    Candelaria D; Randall S; Ladak L; Gallagher R
    Qual Life Res; 2020 Mar; 29(3):579-592. PubMed ID: 31691204
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cardiac Rehabilitation in Patients With Lymphoma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Cardio-oncology Pilot Project.
    Rothe D; Cox-Kennett N; Buijs DM; Venner CP; Paterson DI; Gyenes GT; Pituskin E
    Can J Cardiol; 2018 Oct; 34(10 Suppl 2):S263-S269. PubMed ID: 30201254
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry.
    Bauer T; Zeymer U; Hochadel M; Möllmann H; Weidinger F; Zahn R; Nef HM; Hamm CW; Marco J; Gitt AK
    Int J Cardiol; 2013 Jul; 166(3):596-600. PubMed ID: 22192297
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization.
    Albani S; Fabris E; Doimo S; Barbati G; Perkan A; Merlo M; Gatti G; Di Lenarda A; Van't Hof AWJ; Maras P; Sinagra G
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):195-201. PubMed ID: 29846559
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia.
    Zhang S; Wang W; Sawhney JPS; Krittayaphong R; Kim HS; Nhan VT; Lee SW; Ong TK; Chin CT; Pocock SJ; Huo Y; Qian J; Ge J
    Int J Cardiol; 2020 Jul; 310():16-22. PubMed ID: 32192746
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Correlation of neutrophil-to-lymphocyte ratio with the prognosis of non-ST-segment elevation in patients with acute coronary syndrome undergoing selective percutaneous coronary intervention.
    Wang Z; Wang J; Cao D; Han L
    J Int Med Res; 2020 Oct; 48(10):300060520959510. PubMed ID: 33050747
    [TBL] [Abstract][Full Text] [Related]  

  • 100. An audit of outcomes after same-day discharge post-PCI in acute coronary syndrome and elective patients.
    Hodkinson EC; Ramsewak A; Murphy JC; Shand JA; McClelland AJ; Menown IB; Hanratty CG; Spence MS; Walsh SJ
    J Interv Cardiol; 2013 Dec; 26(6):570-7. PubMed ID: 24112741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.